Altoida is pioneering precision neurology diagnostics to set a new gold standard for patient care. Our innovative AI-driven approach combines novel digital biomarkers with immersive augmented reality to evaluate cognition. The result is our validated device and evidence-based platform with more than 20 years of scientific research. Our products are backed by peer-reviewed publications and multinational clinical trials, and are built by our expert team of scientists, clinicians and engineers. Learn more at www.altoida.com
Empatica is a full-stack digital healthcare company and a pioneer in digital biomarker development and continuous patient monitoring driven by AI. Empatica’s platform consists of medical-grade smartwatches, software, and physiological and behavioural digital biomarkers. Together they enable the continuous remote monitoring of human health across a range of conditions, through clinical-quality digital measurements. Empatica’s solutions are currently being used by thousands of research partners, institutions, and patients, to run decentralized clinical trials, develop novel digital biomarkers, conduct academic research with real-world data, and monitor neurological conditions. Learn more at www.empatica.com
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical measures. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize treatment effect detection in clinical research. Learn more at koneksahealth.com.
VivoSense, Inc., is an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data. We are focused on healthcare research & delivery, clinical trials, and patient wellness. VivoSense’s hypothesis-driven framework provides analytical and clinical validation leading to FDA approval. The proprietary VivoSense® software enables the creation and validation of novel digital biomarkers from wearable sensor data, which constitute primary and secondary clinical endpoints in regulated international pharmaceutical trials. For more information visit www.vivosense.com. We are on Twitter. Follow us @vivosense.
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. Our software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries. www.cambridgecognition.com
Linus Health is a Boston-based digital health company focused on transforming brain health for people across the world. By advancing how we detect, diagnose, and address cognitive and brain disorders – leveraging cutting-edge neuroscience, clinical expertise, and artificial intelligence – our goal is to enable a future where people can live longer, happier, and healthier lives with better brain health. Linus Health’s digital platform delivers a proven, practical means of enabling early detection; empowers providers with actionable clinical insights and recommendations; and supports individuals with personalized action plans. We are proud to partner with leading research institutions, life sciences companies, healthcare delivery organizations, and other care facilities to accelerate more proactive intervention and personalized care in brain health. wwwlinushealth.com
Evidation measures health in everyday life and enables anyone to participate in ground-breaking research and health programs. Built upon a foundation of user privacy and control over permissioned health data, the Evidation app is trusted by millions of individuals—generating actionable insights with unprecedented speed, scale, and rigor.
We’re reimagining engagement to provide a 360 degree view of the patients’ lived experience. Life sciences and healthcare companies partner with us to create new measures of health, reveal critical between care data, and better understand the full patient journey in order to help deliver better health outcomes for millions.
Evidation works across a broad spectrum of therapeutic areas, ranging from cardio metabolic to neurology, immunology and more.
Get started today at evidation.com/partners
LANGaware employs AI to predict neurodegenerative and psychiatric conditions by detecting and monitoring digital biomarkers based on language, voice and speech. Backed by multiple years of research and a USPTO patent, our solution is appropriate for accurate cohort recruitment for clinical trials, and for monitoring the efficacy of the provided treatment.
Radically different from current solutions, LANGaware identifies such diseases very early and with high accuracy, thus allowing for earlier intervention and more timely treatments. Our solution aims to help healthcare providers to forward research, to improve care, and to provide personalized support for individuals facing such challenging health conditions.